Literature DB >> 2088999

Estimation of survival time in terminal cancer patients: an impedance to hospice admissions?

R S Schonwetter, T A Teasdale, P Storey, R J Luchi.   

Abstract

Accurate estimation of survival time in terminal cancer patients is difficult yet may provide useful information. A historical prospective study on 172 patients admitted to a home based hospice service was performed to determine which variables were best correlated with survival time. Mean and median survival were 48 and 22 days, respectively, representing a highly skewed distribution of life span in this sample. As age increased, survival time decreased. All Activities of Daily Living (ADLs) recorded (Bathing, Continence, Dressing and Transfer) as well as other measures of performance (mobility and pulse) and nutrition (appetite and nourishment) were each strongly associated with survival. Multivariate analysis limited significant variables to dressing ability, pulse rate, level of appetite and transferring ability. Outliers (survival greater than 180 days) were differentiated from the remainder of the sample by significant differences in all ADLs recorded as well as the level of appetite. These findings establish the importance of assessing ADLs, a measure of functional status, and reinforce the importance of performance and nutrition measures when estimating length of survival in terminal cancer patients.

Entities:  

Mesh:

Year:  1990        PMID: 2088999     DOI: 10.1080/0742-969x.1990.11882684

Source DB:  PubMed          Journal:  Hosp J        ISSN: 0742-969X


  7 in total

1.  Defining and delineating a duty to prognosticate.

Authors:  B A Rich
Journal:  Theor Med Bioeth       Date:  2001-06

2.  Appropriate time frames for data collection in quality of life research among cancer patients at the end of life.

Authors:  Siew Tzuh Tang; Ruth McCorkle
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

3.  Why don't patients enroll in hospice? Can we do anything about it?

Authors:  Elizabeth K Vig; Helene Starks; Janelle S Taylor; Elizabeth K Hopley; Kelly Fryer-Edwards
Journal:  J Gen Intern Med       Date:  2010-06-10       Impact factor: 5.128

4.  Nimesulide in the treatment of advanced cancer pain. Double-blind comparison with naproxen.

Authors:  F Toscani; M Gallucci; I Scaricabarozzi
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  Prognostic factors for survival in terminal lung cancer patients.

Authors:  R S Schonwetter; B E Robinson; G Ramirez
Journal:  J Gen Intern Med       Date:  1994-07       Impact factor: 5.128

Review 6.  Ethical dilemmas in hospice and palliative care.

Authors:  B M Kinzbrunner
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

7.  Timing of referral of terminally ill patients to an outpatient hospice.

Authors:  N A Christakis
Journal:  J Gen Intern Med       Date:  1994-06       Impact factor: 5.128

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.